home / stock / incr.u:cc / incr.u:cc news

INCR.U:CC News and Press, Intercure Ltd. Ordinary Shares From 03/31/23

Stock Information
Company Name: Intercure Ltd. Ordinary Shares
Stock Symbol: INCR.U:CC
Market: TSXC
Website: intercure.co
Menu
INCR.U:CC INCR.U:CC Quote INCR.U:CC Short INCR.U:CC News INCR.U:CC Articles INCR.U:CC Message Board
Get INCR.U:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
INCR.U:CC - InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results

Record fiscal year 202 2 revenue of $ 150 million Record fiscal year 202 2 Adjusted EBITDA * of $ 3 2 million Record fiscal year 202 2 net income of $ 17 million Generated $20 Million cas...
INCR.U:CC - InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

NEW YORK, TORONTO, and HERZLIYA, Israel, Feb. 14, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“ InterCure ” or the “ Company ”) the biggest and most profitable cannabis company outside of north America, announ...

INCR.U:CC - InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)

NEW YORK and TORONTO and HERZLIYA, Israel, Feb. 01, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (" InterCure " or the " Company ") announces that, further to the merger agreement with Cann Pharmaceutical Ltd. (“ Better ...

INCR.U:CC - InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"

NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 19, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (" InterCure " or the " Compan y "), the largest and fastest growing medical cannabis company outside of North America, today an...
INCR.U:CC - InterCure to Participate in Cowen 5th Annual Cannabis Conference

NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 08, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in Cowen 5 th Ann...

INCR.U:CC - Update regarding Better Transaction

NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 23, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(" InterCure " or the " Company ") is hereby providing an update that further to the announcement from February 16, 2022, regarding...

INCR.U:CC - Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

TORONTO and HERZILA, Israel, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), ( “Organigram”), a leading Canadian licensed producer of cannabis, and Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (NASDAQ: INCR) (TSX:I...
INCR.U:CC - Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

Organigram to supply Israeli pharmaceutical grade cannabis leader InterCure with up to 20,000 kg of dried flower over multiple years Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), ( “Organigram”) a leading Canadian licensed producer of cannabis and Canndoc ...

INCR.U:CC - CORRECTION and MULTIMEDIA UPDATE -- InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth

NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 15, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today, by InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR), please note that multiple numbers were incorrect and have been updated. The corrected release ...

INCR.U:CC - InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth

Eleventh consecutive quarter of sequential profitable revenue growth Annualized revenue run rate of $1 55 million Adjusted EBITDA 1 run rate of $36 million Achieved Run Rate Net Profit of 12 $ million Strong...
Previous 10 Next 10